Extracellular ATP Has Stimulatory Effects on the Expression and Release of IL-6 Via Purinergic Receptors in Normal Human Epidermal Keratinocytes  by Inoue, Kaori et al.
Extracellular ATP Has Stimulatory Effects on the
Expression and Release of IL-6 Via Purinergic Receptors
in Normal Human Epidermal Keratinocytes
Kaori Inoue1, Junichi Hosoi1 and Mitsuhiro Denda1
Extracellular ATP regulates proliferation and differentiation, functioning as an important messenger via
purinergic (P2) receptors in keratinocytes. In this study, we investigated the effects of ATP on cytokine
production in cultured normal human epidermal keratinocytes (NHEKs). Adenosine 50-O-(3-thiotriphosphate)
(ATPgS), adenosine 50-O-2-(thio)diphosphate (ADPbS), ADP, ATP, and 20, 30-O-(4-benzoyl-benzoyl) ATP (BzATP)
significantly increased the release of IL-6. The P2 antagonists, suramin-, reactive blue 2-, and periodate-oxidized
ATP, inhibited ATP-induced IL-6 release, whereas pyridoxal-phosphate-6-azophenyl-20,40-disulfonic acid,
adenosine 30-phosphate 50-phosphate, 1-[N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiper-
azine, and pertussis toxin did not. SQ22563, an adenylate cyclase inhibitor, inhibited ATP-induced IL-6 release.
ATPgS, ADPbS, ATP, and BzATP significantly increased the intracellular cAMP content. Reverse transcription-PCR
showed expression of P2Y1, P2Y2, P2Y4, P2Y11, P2Y12, P2Y13, P2X1, P2X4, P2X5, P2X6, and P2X7 receptor subtypes.
Additionally, UVB radiation evoked the release of ATP from NHEKs. The release of IL-6 and the expression of IL-6
mRNA were increased after UVB radiation, and these increases were also inhibited by P2 receptor antagonists.
These results suggest that cAMP-generating P2Y receptors are likely functional in ATP-induced IL-6 production
in NHEKs. Furthermore, in UVB-radiated cells, we note the possibility that P2 receptor antagonists may reduce
skin inflammation.
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INTRODUCTION
The skin is one of the largest organs of the body and is the first
site of exposure to various harmful environmental factors
such as infection and UV radiation. Cytokines are important
precursors that mediate the host defense response to injury
and infection. Keratinocytes are a major source of cytokines
and have been reported to secrete IL-1, IL-6, IL-8, tumor
necrosis factor a (TNFa), transforming growth factor b, and
platelet cell-derived growth factor (Schwarz and Luger, 1989;
Ansel et al., 1990). Production of cytokines is increased in
response to environmental stimuli. For instance, UVB
radiation stimulates the production of IL-6 (Kirnbauer et al.,
1991) and IL-8 (Kondo et al., 1993) in keratinocytes.
Production of IL-8 is upregulated by thermal injury (Bowman
et al., 1997). Additionally, many investigators have reported
that the release of cytokines is induced by a number of
inflammatory mediators such as substance P or histamine
(Song et al., 2000; Kohda et al., 2002).
ATP is released from a variety of tissues (Milner et al.,
1990; Hansen et al., 1993; Ferguson et al., 1997), and acts as
one of the mediators that transmit signals to the central and
peripheral nervous systems (for reviews, see Ralevic and
Burnstock, 1998; Lambrecht, 2000; North and Surprenant,
2000). P2 receptors are classified broadly within two families:
ligand-gated ion channels (P2X) and G-protein-coupled
metabotropic receptors (P2Y). P2Y1, P2Y2, P2Y4, and P2Y6
receptor subtypes are coupled to phospholipase C via Gq/11
protein. P2Y12, P2Y13, and P2Y14 receptors are coupled to
adenylate cyclase via Gi protein (Communi et al., 2001;
Zhang et al., 2002; Abbracchio et al., 2003). Activation of
P2Y1 receptors also results in the inhibition of adenylate
cyclase via Gi protein. P2Y11 receptors are coupled to both
phospholipase C via Gq/11 protein and adenylate cyclase via
Gs protein (Communi et al., 1997). P2X receptors have seven
subtypes (P2X1–7) and form heteromeric or homomeric
channel assemblies. ATP regulates cell growth, differentia-
tion, terminal differentiation, and cell-to-cell communication
in keratinocytes (Pillai and Bikle, 1992; Dixon et al., 1999;
Greig et al., 2003; Koizumi et al., 2004; Burrell et al., 2003,
2005; Inoue et al., 2005). Furthermore, keratinocytes
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constantly release ATP whether or not the skin is damaged
(Dixon et al., 1999; Cook and McCleskey, 2002). In
response to cell damage by irritant chemicals or mechanical
stimulation, ATP is immediately released from keratinocytes
(Mizumoto et al., 2003; Koizumi et al., 2004). Extracellular
ATP causes the release of IL-1 in human macrophages
(Ferrari et al., 1997), the release of IL-1b, and TNFa in
human dendritic cells (Ferrari et al., 2000). Moreover, the
release of cytokines is regulated through P2 receptors in a
variety of cells. Within the dermis, ATP causes the release of
IL-6 via P2X7 receptors in human fibroblasts (Solini et al.,
1999) and adenosine 50-O-(3-thiotriphosphate) (ATPgS)
causes the release of IL-6 via P2Y2 and P2Y11 receptors in
human dermal microvascular endothelial cell line (Seiffert
et al., 2006).
In this study, in order to investigate whether extracellular
nucleotides induce IL-6 production in epidermal cells, we
examined which of the P2 receptors are functional during
ATP-induced release or production of IL-6 in cultured normal
human epidermal keratinocytes (NHEKs). As UVB radiation,
a major environmental stimulus, causes the release of IL-6
from keratinocytes, we also investigated whether or not the
involvement of purinergic signaling was involved in UVB
radiation-induced IL-6 release.
RESULTS
Extracellular nucleotides increase the release of IL-6 from
keratinocytes via P2 receptors
Extracellular ATP causes the release of IL-6 in a variety of
cells (Solini et al., 1999; Shigemoto-Mogami et al., 2001;
Hanley et al., 2004; Caraccio et al., 2005; Seiffert et al.,
2006). As keratinocytes are a major source of cytokine
release (Schwarz and Luger, 1989; Ansel et al., 1990), we
examined the effects of extracellular nucleotides on the
release of IL-6 from NHEKs. Figure 1a shows the time course
for extracellular ATP-induced IL-6 release from NHEKs. Next,
we examined the effects of various concentrations of
nucleotides on the release of IL-6. These nucleotides
increased the release of IL-6 in a dose-dependent manner
(24 hours incubation; Figure 1b). ATPgS, adenosine 50-O-2-
(thio)diphosphate (ADPbS), ADP, ATP, and 30-O-(4-benzoyl-
benzoyl) ATP (BzATP) significantly increased the release of
IL-6 compared to basal release. The response to ATPgS and
ADPbS was significantly higher compared to the response to
ATP at concentration of 300mM. On the other hand, UTP,
UDP, 2-methylthio-ATP, 2-methylthio-ADP, or a, b-methyl-
ene ATP had no effect (Figure 1b).
We then examined the effect of P2 receptor antagonists on
the release of IL-6. Figure 2a shows the concentration
400
300
500
400
300
200
100
0
200
100
0 10 20 30 40 50
Control
ATP
*
**
***
***
Hour
ATP UTP ADP UDP ATPS 2-meSATP 2-meSADPADPS ,- meATPBzATP
IL
-6
 re
le
as
e 
(pg
/m
l)
IL
-6
 re
le
as
e 
(pg
/m
l)
0
10
30
100
300
1,000
a
b
*
*
*
*
**
*****
***
***
***
***
***
***
Figure 1. Effects of nucleotides on the release of IL-6 from NHEKs. (a) Time course for IL-6 release from NHEKs due to extracellular ATP. Culture supernatants
were collected at 2, 6, 24, and 48 hours, and the content of IL-6 was measured by ELISA. The data represent the mean7SD of two independent experiments.
*Po0.05, **Po0.01, and ***Po0.001 indicate a statistically significant difference compared to cells that were not treated. (b) Effects of various nucleotides
on the release of IL-6. After 24 hours, culture supernatants were collected and the content of IL-6 was measured by ELISA. The data represent the mean7SD
of three independent experiments.
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dependency of the inhibitory effects of P2 receptor antago-
nists on ATP-induced IL-6 release. Suramin (30–1,000 mM) and
reactive blue 2 (RB2) (30–1,000 mM) inhibited ATP-induced
IL-6 release. RB2 had more potent antagonizing effects than
suramin. On the other hand, pyridoxal-phosphate-6-azophe-
nyl-20,40-disulfonic acid (PPADS) (1,000mM) did not inhibit
ATP-induced IL-6 release up to 300mM. Adenosine 30-
phosphate 50-phosphate, a P2Y1 receptor antagonist, did not
inhibit the release of IL-6 (Figure 2a). Furthermore, pretreat-
ment with pertussis toxin (PTX) (100 ng/ml) did not affect
ATP-induced IL-6 release (Figure 2b). ATP or BzATP (100mM)-
induced IL-6 release was inhibited in the presence of
periodate-oxidized ATP (oATP), an irreversible inhibitor of
P2X7 receptors (Murgia et al., 1993) (Figure 2c). However,
1-[N,O-bis(1,5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-
4-phenylpiperazine (KN-62), the most potent P2X7 receptors
antagonist in the nanomolar range (Gargett and Wiley,
1997), did not inhibit ATP or BzATP (100mM)-induced IL-6
release (Figure 2d). SQ22563 (3 mM), an adenylate cyclase
inhibitor, inhibited ATPgS (100 mM)-induced IL-6 release
(Figure 2e). SQ22563 (3 mM) did not alter the basal level
of IL-6.
Extracellular nucleotides increase the production of IL-6 from
keratinocytes
Using quantitative reverse transcription (RT)-PCR methods,
we examined whether or not the presence of extracellular
nucleotides increased the expression of IL-6 mRNA in
NHEKs. The expression of IL-6 mRNA was significantly
increased by the application of ATP, ATPgS, ADP, and
ADPbS, which increased the release of IL-6. BzATP,
2-methylthio-ADP, UTP, UDP, and a, b-methylene ATP did
not significantly induce IL-6 mRNA expression (Figure 3a).
Suramin (100mM) and RB2 (100 mM) inhibited the ATP-
induced expression of IL-6 mRNA. However, PPADS
(100 mM) had no effect (Figure 3b).
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Figure 2. Effects of the P2 receptor antagonists, PTX, or SQ22563 on ATP- or BzATP-induced IL-6 release in NHEKs. (a) Concentration dependency of
inhibitory effects of P2 receptor antagonists on ATP-induced IL-6 release. After 24 hours, culture supernatants were collected and the content of IL-6 was
measured by ELISA. Prior to ATP application, cells were pretreated for 15 minutes with P2 receptor antagonists (suramin, RB2, PPADS, or adenosine
30-phosphate 50-phosphate (A3P5PS)). (b) Effect of PTX on ATP-induced IL-6 release. Prior to ATP application, cells were pretreated for 24 hours with PTX
(100 ng/ml). (c) Effects of oATP on ATP- and BzATP-induced IL-6 release. Prior to ATP or BzATP (100 mM) application, cells were pretreated for 15 minutes
with oATP. (d) Effects of KN-62 on ATP- and BzATP-induced IL-6 release. Prior to ATP or BzATP (100 mM) application, cells were pretreated for 15 minutes with
KN-62. (e) Effects of SQ22563 on ATP-induced IL-6 release. Prior to ATP (100 mM) application, cells were pretreated for 15 minutes with SQ22563. The data
represent the mean7SD of two or three independent experiments. ***Po0.001 indicates a statistically significant difference in comparison to cells that were not
treated. #Po0.05, ##Po0.01, and ###Po0.001 indicates a statistically significant difference comparison to cells in which ATP or BzATP (100 mM) were applied
(analysis of variance test and Scheffe’s test).
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Extracellular nucleotides increase intracellular cAMP content
As SQ22563 inhibited the release of IL-6 induced by ATP
(Figure 2e), we measured whether or not extracellular
nucleotides had any effect on intracellular cAMP content.
Although no significant differences were found among the
nucleotides, ATPgS, ATP, BzATP, and ADPbS significantly
increased the intracellular cAMP content compared to basal
content (Figure S1). Among P2Y receptor subtypes, only
P2Y11 receptors are positively coupled to adenylate cyclase
via Gs protein (Communi et al., 1997). The observed pattern
of nucleotides on cAMP levels was similar to the increases of
cAMP mediated via P2Y11 receptors (Communi et al., 1997,
1999; Wilkin et al., 2001).
Human epidermal keratinocytes express the mRNA for P2Y and
P2X receptor subtypes
The expression patterns of multiple P2Y and P2X receptor
subtypes were analyzed by RT-PCR. We confirmed the
presence of all P2 receptors using human reference total RNA
as a positive control (Figure 4). With respect to P2Y11
receptors, we also confirmed using thrombospondin-1 as a
positive control. The expression of P2Y1, P2Y2, P2Y4, P2Y11,
P2Y12, P2Y13, P2X1, P2X4, P2X5, P2X6, and P2X7 receptor
subtypes was present in all cell batches. Although the
expression levels of P2 receptors varied in all samples,
P2Y1, P2Y11, and P2X5 receptor subtypes were consistently
expressed. With respect to the expression of P2Y1, P2Y2,
P2Y4, and P2Y11 receptor subtype mRNA, the RT-PCR results
coincide with previous research (Dixon et al., 1999; Burrell
et al., 2003; Koizumi et al., 2004). The expression of P2Y2
was detected in three of four strains. Although the expression
of P2Y6 receptors has been demonstrated in NHEKs (Burrell
et al., 2003), its expression was not detected in either strain
we used. The expression of P2Y12 was detected in one of four
strains. P2Y13 was detected in two of four strains. P2Y14
receptors were not expressed. Except for the expression of
P2X6 receptors, the expression patterns of P2X receptors were
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Figure 3. Effects of nucleotides and P2 receptor antagonists on the
expression of IL-6 mRNA using quantitative RT-PCR. (a) Extracellular
nucleotides (300 mM) increased the expression of IL-6 mRNA using
quantitative RT-PCR methods. IL-6 mRNA levels were normalized for
GAPDH mRNA levels. Data are relative to control (untreated cells), which is
set at 1. PCR products were electrophoresed in 2% agarose gel (top). M,
DNA size marker. (b) Effects of ATP and its antagonists on the expression
of IL-6 mRNA. Cells were treated with purinergic receptor antagonists
(100mM) for 15 minutes, and then stimulated with ATP (300 mM) for 6 hours.
IL-6 mRNA levels were normalized for GAPDH mRNA levels. The data
represent the mean7SD of three independent experiments. *Po0.05
indicates a statistically significant difference compared to cells that were not
treated. #Po0.05 indicates a statistically significant difference compared to
cells in which ATP (300 mM) was applied (analysis of variance test and
Scheffe’s test). PCR products were electrophoresed in 2% agarose gel
(bottom).
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Figure 4. Expression of P2 receptor subtype mRNA in NHEKs. PCR products
for P2 receptors and GAPDH after 40 cycles were obtained using cDNA
from NHEKs. Lanes 1–4 were keratinocyte samples from four strains.
Lane 5 was an amplification without a template. Human reference total
RNA was used as a positive control for expression of all the P2 receptors.
THP-1 cells were also used as a positive control for P2Y11 receptors. M,
DNA size marker.
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similar to those of found in a previous report (Inoue et al.,
2005). The expression of P2X1 was detected in three of four
strains. The expression of P2X4 was detected in three of
four strains. The expression of P2X7 was detected in two
of four strains. The expression of P2X6 was detected in one of
four strains. The expression of P2X2 and P2X3 receptors was
not expressed in all batches.
P2 receptor antagonists also inhibit the release and the
expression of IL-6 in UVB-radiated cells
UV radiation induces the release of a variety of cytokines
from keratinocytes (Ansel et al., 1983; Kupper et al., 1987;
Kondo et al., 1993). In order to confirm the P2 receptorial
system in mediating UV-induced IL-6 production, we
investigated whether P2 receptor antagonists (100 mM) in-
hibited the release of IL-6 in UV-radiated keratinocytes. UVB
(30 or 60 mJ/cm2) stimulated IL-6 release. Cytotoxicity was
observed in keratinocytes exposed to UVB (60 mJ/cm2)
conditions for 24 hours (proliferating sub-confluent kera-
tinocytes; 1,521763, n¼ 4, proliferating sub-confluent
keratinocytes exposed to UVB (30 mJ/cm2); 1,478752, n¼4,
proliferating sub-confluent keratinocytes exposed to UVB
(60 mJ/cm2); 725772, n¼ 4). These increases were inhibited
by suramin, RB2, or PPADS in UVB (30 mJ/cm2)-radiated
cells (Figure 5a). The increases were only inhibited by RB2 in
UVB (60 mJ/cm2)-radiated cells (Figure 5a). Using quantita-
tive RT-PCR methods, we examined the effects of P2 receptor
antagonists on the expression of IL-6 mRNA in UV-radiated
cells. UVB (30 mJ/cm2) increased IL-6 mRNA expression.
These increases were inhibited by suramin, RB2, and PPADS
(Figure 5b and c). Furthermore, we confirmed whether
keratinocytes were able to release ATP after UVB radiation.
Figure 5d shows that UVB radiation immediately increased
both extracellular and total cellular ATP content in NHEK.
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Figure 5. Effects of P2 receptor antagonists on the release or the expression of IL-6 in UVB-radiated cells. (a) UVB (30 or 60 mJ/cm2) stimulated IL-6 release.
Cells were pretreated for 15 minutes with 100 mM suramin, 100mM PPADS, or 100 mM RB2 prior to UVB radiation. After 24 hours, culture supernatants were
collected and the content of IL-6 was measured by ELISA. The data represent the mean7SD of three independent experiments. ***Po0.001 indicates a
statistically significant difference in comparison to cells that were not treated. #Po0.05, ##Po0.01, and ###Po0.001 indicates a statistically significant difference
in comparison to cells that were exposed to UVB radiation. (b and c) UVB (30 or 60 mJ/cm2) increased IL-6 mRNA expression. Cells were pretreated with
P2 receptor antagonists (100 mM) for 15 minutes before UVB radiation, and total RNA was then isolated for 6 hours after UVB radiation. IL-6 mRNA levels were
normalized for GAPDH mRNA levels. PCR products were electrophoresed in 2% agarose gel. M, DNA size marker. The data represent the mean7SD of three
independent experiments. ***Po0.001 indicates a statistically significant difference in comparison to cells that were not treated. ###Po0.001 indicates
a statistically significant difference in comparison to cells that were exposed to UVB radiation. (d) Release of ATP from NHEKs caused by UVB radiation.
The content of ATP was measured by an ATP determination kit. The data represent the mean7SD of two independent experiments. ***Po0.001 indicates
a statistically significant difference in comparison to untreated cells (analysis of variance test and Scheffe’s test).
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DISCUSSION
Extracellular ATP regulates cell growth, differentiation, and
terminal differentiation in keratinocytes (Pillai and Bikle,
1992; Dixon et al., 1999; Greig et al., 2003; Burrell et al.,
2003, 2005; Inoue et al., 2005). The majority of P2Y1 and
P2Y2 receptors in human skin are expressed in the basal layer
and their localization is associated with the proliferation
stage (Dixon et al., 1999; Greig et al., 2003). However, the
expression of P2Y2 mRNA is downregulated in differentiating
HaCaT keratinocytes or NHEKs (Koegel and Alzheimer,
2001; Burrell et al., 2003). The localization of P2X5 and
P2X7 receptors is associated with the differentiated stage or
terminal differentiated stage (Greig et al., 2003). Furthermore,
the expression of multiple P2X receptor subtypes and the
responses to Ca via P2X receptors are enhanced in the
differentiated phase (Inoue et al., 2005). Moreover, in
response to cell damage by irritant chemicals or mechanical
stimulation, ATP is immediately released from keratinocytes
(Mizumoto et al., 2003; Koizumi et al., 2004). These events
indicate that the regulation of ATP and P2 receptors play a
crucial role in the skin.
Firstly, as mentioned above there are a variety of P2
receptors that are functional in keratinocytes; we investigated
which P2 receptor subtypes contribute to IL-6 production.
Judging by high level of P2Y11 receptor expression, ability to
generate cAMP, their insensitivity to PPADS, their sensitivity
to SQ22563, and their agonist sensitivity, there is a possibility
that P2Y11 receptors mediate ATP-induced IL-6 production.
P2Y11 receptors are sensitive to the following agonists:
ATPgS, BzATP, ATP, and ADPbS (Communi et al., 1999).
Indeed, exposure to these nucleotides increased the release
and production of IL-6 (Figures 1 and 3). They also increased
the intracellular cAMP content (Figure S1). Our results
suggest that in proliferating sub-confluent cells, Gs protein-
coupled P2Y receptors have a dominant role in ATP-induced
IL-6 production. Although the functional role of P2Y11
receptors remains unclear in keratinocytes, they may partially
contribute to cell growth as the activation of adenylate
cyclase leads to proliferation in keratinocytes. Although ADP
is a partial agonist for hP2Y11 receptors (Qi et al., 2001), the
effect of ADP was more potent than that of ATP on the release
of IL-6 (Figure 1b). ADP also increased the expression of IL-6
mRNA (Figure 3). ADP converts ATP by ecto-adenylate
kinase, ecto-F1F0ATP synthase, and ecto-nucleotide dipho-
sphokinase in human keratinocytes (Burrell et al., 2005). This
may have caused some overlap in the ADP-induced
response. Additionally, the rank order of antagonist potency
on the release of IL-6 (RB4suramin4PPADS) did not match
that of the defined human P2Y11 receptors (Communi et al.,
1999). At present, although we cannot conclusively identify
a new type of P2 receptor, our evidence strongly suggests
that cAMP-generating P2Y receptors are responsible for the
ATP-induced IL-6 production. Further research is required to
clarify these points.
Judging by their sensitivity to agonists and antagonists, the
contribution of P2Y1, P2Y2, P2Y4, P2Y12, P2Y13, P2X1, P2X4,
P2X5, P2X6, and P2X7 receptor subtypes expressed in NHEKs
was not eliminated. Although P2Y1, P2Y12, and P2Y13
receptors were expressed in NHEKs, their contribution seems
minimal as the ATP-induced IL-6 release was not influenced
by PTX or adenosine 30-phosphate 50-phosphate (Figure 2).
Furthermore, the expression of P2Y2 and P2Y4 receptor
subtypes was detected in NHEKs (Figure 4); the lack of
sensitivity to UTP indicates that P2Y2 and P2Y4 receptor
subtypes are not responsible for ATP-induced IL-6 release.
Although P2Y1 and P2Y2 receptors play an important role in
proliferation, contrary to our expectation, they were not
involved in the release or gene expression of IL-6. PPADS is a
non-selective P2X/P2Y receptor antagonist, and blocks
homomeric P2X1, P2X2, P2X3, and P2X5 (Lambrecht, 2000).
Although PPADS has no effect on rat P2X4 receptors, PPADS
does antagonize human P2X4 receptors (Garcia-Guzman
et al., 1997; Jones et al., 2000). The lack of sensitivity to a,
b-methylene ATP or 2-methylthio-ATP, or the absence of
inhibitory effects by PPADS at 10 mM indicates that P2X1–6
receptors are not responsible for ATP-induced IL-6 release. As
KN-62 did not have any inhibitory effects in the ATP- or
BzATP-induced release of IL-6, we believe that oATP too may
not have had any antagonizing effects on the P2X7 receptor,
rather it produced inhibition by reducing proinflammatory
responses via nuclear factor-kB activation (Beigi et al., 2003;
Di Virgilio, 2003). We can therefore exclude the involvement
of P2X7 receptor subtypes on the release of IL-6.
Proinflammatory cytokines such as IL-1a, IL-1b, and TNFa,
enhance the synthesis and release of IL-6 in keratinocytes
(Kirnbauer et al., 1989; Ansel et al., 1990; Partridge et al.,
1991). ATP causes the release of IL-1b and TNFa in
lipopolysaccharide-matured human macrophages (Ferrari
et al., 1997); however, there may be overlap in our
experiments as the ATP-induced IL-6 release may be due to
a direct or indirect response namely, via IL-1 or TNFa.
Conditioned medium from keratinocyte cultures induce IL-6
secretion in post-mitotic human dermal fibroblast feeder
cells; in contrast, the conditioned medium from post-mitotic
human dermal fibroblast feeder layers leads only to minimal
increases of keratinocyte IL-6 production (Waelti et al.,
1992). As ATP stimulates IL-6 secretion in bacterial endo-
toxin-stimulated human fibroblasts (Solini et al., 1999),
keratinocyte-derived cytokines may play a synergistic
role in IL-6 production in the skin. Additional studies using
anti-IL-1 or TNFa antibody are required.
In human monocyte-derived dendritic cells, nucleotides
induce cytokine release via P2Y11 receptors (Wilkin et al.,
2001). Nucleotides also induce cytokine release via P2Y2 and
P2Y11 receptors in human dermal vascular endothelium cell
lines (Seiffert et al., 2006). On the other hand, lipopolysac-
charide-induced secretion of proinflammatory cytokines
(TNFa and monocyte chemoattractant protein-1) is inhibited
by ATPgS via P2Y11 receptors (Kaufmann et al., 2005). In
human IL-4-primed mast cells, nucleotides inhibit TNFa
production via Gs-coupled P2 receptors (Feng et al., 2004).
These reports suggest that P2Y11 receptors as having an
immunomodulatory roll in a variety of cells. Purinergic
pathways seem to have an important immunomodulatory role
via P2Y11 receptors that interact with skin cells and
neighboring cells including immune cells.
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Secondly, as UVB or UVA radiation directly induces the
release of a variety of cytokines from keratinocytes, we
examined whether the purinergic pathway contributes to IL-6
production under UV inflammation (Ansel et al., 1983;
Kupper et al., 1987; Kirnbauer et al., 1991; Kondo et al.,
1993; Tebbe et al., 1997). As cytotoxicity and a large amount
of extracellular and total cellular ATP were observed in cells
that were exposed to UVB (Figure 5), we believe it is likely
that ATP is a triggering factor that generates the release of
IL-6. We applied a nucleotide-hydrolyzing enzyme, apyrase,
in order to clarify the role of ATP in UVB-induced IL-6
release. As a high concentration of calcium induces signaling
pathways of differentiation within a few hours, we could not
use a concentration of more than 150mM. Under this
circumstance, apyrase (10 U/ml) had no effect on UV-
induced IL-6 release (data not shown). UV radiation induces
the release of a variety of inflammatory mediators from
keratinocytes. For example, the release of endogenous
histamine in UVB injury induces prostaglandin synthesis in
human skin (Pentland et al., 1990). Under these circum-
stances, why did P2 receptor antagonists inhibit both UVB-
induced IL-6 release and IL-6 mRNA expression? Even at
24 hours, apyrase had no effect on the release of IL-6 in
untreated or UVB-radiated cells (data not shown). In the
presence of cAMP-elevating drugs, IL-6 production is
enhanced in the UVB-radiated human keratinocytes
NCTC2544 cell line, and continues to be inhibited by protein
kinase A inhibitors in the same experimental condition
(Grandjean-Laquerriere et al., 2003). Inhibition of P2
antagonists may indirectly result in the inhibition of the
activation of Gs-protein kinase A signaling by prostaglandin.
In fact, ATP increases the prostaglandin content in rat urinary
bladder (Kasakov and Vlaskovska, 1985). In response to
irritant chemicals, UVB radiation, and mechanical stimula-
tion, ATP is immediately released into extracellular space and
appears to be acting as an initial signal that amplifies the
actions of other mediators. Therefore, we speculated
that purinergic antagonists might have an anti-inflammatory
effect on the initial stage in inflammation. In UVB
(60 mJ/cm2)-radiated cells, only the inhibitory effects of RB2
may be mediated through a mechanism other than the P2
receptors. However, the exact mechanisms could not yet be
confirmed.
In conclusion, human keratinocytes express several P2
receptors of which cAMP-generating P2Y receptors are likely
functional in IL-6 production. The inhibitory responses of IL-6
release by P2 receptor antagonists indicate that ATP may be
partially responsible for an important physiological role as an
initial signal to the inflammatory response. Furthermore, in
UVB-radiated cells, we note the possibility that P2 receptor
antagonists may reduce skin inflammation.
MATERIALS AND METHODS
Cells and cell culture
NHEKs (four strains of NHEKs) were purchased from Kurabo (Osaka,
Japan). Cells were plated in collagen-coated culture flasks (Falcon,
Becton Dickinson Labware, Franklin Lakes, NJ), and cultured in
serum-free keratinocyte growth medium, Humedia-KB2 (Kurabo,
Osaka, Japan), supplemented with bovine pituitary extract (0.4%
(v/v)), human recombinant epidermal growth factor (0.1 ng/ml),
insulin (10 mg/ml), and hydrocortisone (0.5 mg/ml). Hydrocortisone
was removed from the medium 48 hours prior to collection of
culture supernatants. The medium was replaced every 2–3 days.
Human monocyte cell line, THP-1 (Tsuchiya et al., 1980), was
purchased from American Type Culture Collection (Manassas, VA).
Cells were grown at 371C in Roswell Park Memorial Institute
medium supplemented with 10% fetal calf serum in a humidified
atmosphere of 5% CO2 in air.
Reagents
PTX was purchased from ALEXIS Biochemicals (San Diego, CA). KN-
62 was purchased from Seikagaku Corporation (Tokyo, Japan). All
nucleotides and other drugs were purchased from Sigma-Aldrich (St
Louis, MO).
Determination of IL-6 in supernatants
Cells were plated in collagen-coated 12-well culture plates (2 ml of
1 104 cells/well) (Falcon, Becton Dickinson Labware, Franklin
Lakes, NJ) and cultured for 3 days at 371C in a humidified
atmosphere containing 5% CO2. Hydrocortisone was removed from
the medium at day 4. When the cells reached sub-confluence at day
5, the medium was removed and the hydrocortisone-free fresh
medium was re-applied along with a number of nucleotides for
24 hours. Kirnbauer et al. (1991) reported that hydrocortisone
affected IL-6 production; therefore, it was removed 48 hours before
cells were tested. After 24 hours, culture supernatants were
collected. In order to measure the time course of IL-6 release, the
medium was collected at 2, 6, 24, and 48 hours.
Before applying ATP or BzATP cells were pretreated for 15 min
with P2 antagonists (suramin, PPADS, RB2, adenosine 30-phosphate
50-phosphate, oATP, KN-62) or SQ22563, an adenylate cyclase
inhibitor. PTX (100 ng/ml) was pretreated for 24 hours before
application of ATP.
For the determination of IL-6 in UVB-radiated cells, cells
were grown in 35 mm collagen-coated dish. After exposing cells
to radiation, the medium was added back to the dishes and
cells were incubated at 371C in 5% CO2 for 24 hours. Before UVB
radiation (30 and 60 mJ/cm2), 60–80% confluent cells were
pretreated for 15 minutes with 100 mM suramin, 100 mM PPADS, or
100mM RB2.
After 24 hours, culture supernatants were collected and then
centrifuged at 1,000 g for 10 minutes, and stored at 301C for
ELISA. All experiments were performed two or three times in
duplicate. A commercially available ELISA kit was used for
measuring human IL-6 (QuantikineR, R&D System, Minneapolis,
MN) according to the manufacturer’s protocol. The minimum
detectable dose of IL-6 is typically less than 0.7 pg/ml.
UVB radiation
While applying UV radiation, the medium was replaced by
phosphate-buffered saline (). Cells were exposed to UVB radiation
from a bank of two Toshiba FL 20 SE sunlamps (Toshiba Electric,
Tokyo, Japan). These tubes emit wavelengths between 280 and
340 nm, with a peak of 304 nm. Radiance was measured by a UV-
Radiometer (Topcon, Tokyo, Japan). For ATP determination studies,
cells were radiated in the medium.
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cDNA synthesis and PCR amplification
For RT-PCR studies, cells were grown in collagen-coated six-well
plates until 60–80% confluency. Cells were treated with nucleotides
(300mM) for 6 hours. After exposing cells to UVB radiation (30 or
60 mJ/cm2), the medium was added back to the dishes and cells were
incubated at 371C in 5% CO2 for 6 hours. Cells were pretreated for
15 minutes with 100 mM suramin, 100mM PPADS, or 100mM RB2
before application of ATP or UVB radiation (30 and 60 mJ/cm2).
Total RNA was isolated from all individual samples using ISOGEN
(Nippon Gene, Osaka, Japan) according to the manufacturer’s
protocol. We synthesized cDNA from 1 mg of total RNA by the use of
200 U of Moloney-murine leukemia virus RT (Invitrogen, Carlsbad,
CA) in 20 ml of reaction mixture containing 0.5 mg of oligo(dT) primer
(Invitrogen), 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2,
10 mM dithiothreitol, 0.25 mM dATP, 0.25 mM dTTP, 0.25 mM dGTP,
0.25 mM dCTP (Takara, Otsu, Japan), and 50 U of ribonuclease
inhibitor (Takara) at 371C for 1 hour. P2 receptor cDNA and human
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) cDNA in
samples were amplified by using ABI PRISMTM 7700 sequence
detector (Applied BioSystems, Foster City, CA). The reaction mixture
was as follows: PCR buffer, 3.5 mM MgCl2, 0.2 mM forward primer,
0.2 mM reverse primer, 0.2 mM dNTP, and 1.25 U of AmpliTaq GoldTM
DNA polymerase (Applied BioSystems, Foster City, CA). The PCR
conditions were as follows: 501C for 2 minutes; 951C for 10 minutes;
40 cycles of 951C for 15 s, and 601C for 1 minute. Obtained DNA
fragments by PCR were separated in 2% agarose in Tris-borate buffer
containing 0.25 mg/ml ethidium bromide. DNA size maker (Marker
10, Nippon gene, Japan) was loaded in the same gel. The gel was
visualized by UVB radiation. PCR primers were designed using
Genetyx Software program (Genetyx Co, Japan). The list of primers
(forward, reverse, accession number, and product size) for P2Y and
P2X receptors are shown in Tables S1 and S2, respectively. Human
reference total RNA was used as a positive control for the expression
of all the P2 receptors. BDTM qRNA human reference total RNA
(Clontech Laboratories Inc., Mountain View, CA) is a mixture of total
RNAs from multiple adult human tissues chosen to represent a broad
range of expressed genes. As P2Y11 receptor subtypes are expressed
in human dendritic cells (Wilkin et al., 2001), a human monocyte
leukemia cell line THP-1 was also used as a positive control for
P2Y11 receptors.
Quantitative RT-PCR
The amounts of IL-6 cDNA and GAPDH cDNA in samples were
measured by quantitative PCR using 50nuclease assay and ABI
PRISMTM 7700 sequence detector (PE Applied BioSystems, Forster
City, CA) (Gibson et al., 1996). The reaction mixture was as follows:
PCR buffer, 3.5 mM MgCl2, 0.3 mM forward primer, 0.3 mM reverse
primer, 0.3 mM fluorescein probe, 0.2 mM dATP, 0.4 mM dUTP,
0.2 mM dGTP, 0.2 mM dCTP, 0.5 U of uracyl N-glycosylase,
which prevents carry-over contamination from previously amplified
DNA (Loewy et al., 1994), and 1.25 U of AmpliTaqTM DNA poly-
merase. The PCR conditions were: 501C for 2 minutes; 951C for
10 minutes; 40 cycles of 951C for 15 seconds; and 601C for 1 minute.
Preparation of standard templates for quantitative PCR was
performed all without distinction according to the previously
described report (Shibata et al., 1999). Nucleotide sequences for
PCR primers and probes were as follows: IL-6 forward primer, 50-
GAACTCCTTCTCCACAAGCG-30; reverse primer, 50-AGATGCCGTC
GAGGATGTA-30; probe, 50-TTCGTTCTGAAGAGGTGAGTGGCTG-30
(40 cycles); and IL-8 forward primer, 50-TCAGAGACAGCAGAGCAC
ACA-30; reverse primer, 50-CTTGGCAGCCTTCCTGATT-30; probe, 50-
AACATGACTTCCAAGCTGGCCA-30 (40 cycles); GAPDH as an
internal control forward primer, 50-GAAGGTGAAGGTCGGAGTC-30;
reverse primer, 50-GAAGATGGTGATGGGATTTC-30; probe, 50-AGGC
TGAGAACGGGAAGCTTG-30 (40 cycles). The PCR products were
separated in 2% agarose in 1 Tris-borate buffer containing 0.25mg/ml
ethidium bromide. The gel was visualized by UVB radiation.
Determination of cAMP
Cells (105 cells/well) were plated in collagen coated 96-well plates
and cultured in serum-free keratinocyte growth medium, consisting
of Humedia-KB2 (Kurabo, Japan) and supplemented with, both
human recombinant epidermal growth factor (0.1 ng/ml) and insulin
(10 mg/ml) for 24 hours. Cells were preincubated with 3 mM 2-[4-(2-
hydroxyethyl)-1-piperazinyl]ethanesulfonic acid buffer, pH 7.4,
containing 140 mM NaCl, 4 mM KCl, 2.5 mM CaCl2, and 1 mg/ml of
BSA with 0.5 mM 3-methylisobutylxanthine for 30 minutes, and
incubated for 20 minutes in the presence of nucleotides. Intracellular
cAMP contents were assessed using the cAMP enzymeimmunoassay
Biotrak TM system (Amersham Bioscience, UK). The results were
expressed as mean values of three independent experiments.
Cell viability
The condition of 24 hours post-treatment with UVB (30 and 60 mJ/
cm2) on the cell viability was assessed with an alamarBlueTM assay
(Alamar Biosciences, Camarillo, California), according to the
manufacturer’s protocol. The fluorescence intensities were deter-
mined at 544 and 590 nm.
ATP determination
In order to measure total and extracellular ATP content in
keratinocytes, we applied the methods established by Caraccio
et al. (2005) with minor modifications. In brief, cells were placed in
a collagen-coated 96-well black plate (100ml of 2 103 cells/well)
(Perkin-Elmer Ltd., Beaconsfield, UK), and then cultured for 4 days at
371C. Before ATP measurements, the medium was removed and
a fresh medium (50 ml) was re-applied. Cells were either exposed to
or not UVB radiation. The wells were then filled with 100 ml of ATP-
Lite (buffer solutionþ substrate solution with D-luciferin and
luciferase (ATPLiteTM, Perkin-Elmer Ltd). The plates were directly
placed on a luminometer (Fluoroskan Ascent FL, Thermo Electron
Corporation, Waltham, MA) and light emission was recorded to
determine the extracellular ATP content. Cells were then shaken for
5 min in the lysis solution, and measured to determine the total
cellular ATP content. ATP standard solution was diluted in the
medium.
Statistics
Data represent the mean7SD. Statistical differences between two
groups were determined by a two-tailed Student’s t-test. In the case
of more than two groups, differences were analyzed by analysis of
variance test and Scheffe’s test. Po0.05 was considered to be
statistically significant.
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SUPPLEMENTARY MATERIAL
Figure S1. Effects of extracellular nucleotides on the intracellular cAMP
contents in normal human epidermal keratinocytes (NHEKs).
Table S1. Primers list of P2Y receptors and glyceraldehydes-3-phosphate
dehydrogenase (GAPDH).
Table S2. Primers list of P2X receptors.
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